Gene Therapy Approaches to Replace or Restore Dystrophin PF-06939926 – Kasia Lobello, MD (Pfizer, Inc.) RGX-202 – Jahannaz Dastgir, DO (REGENXBIO) scAAV9.U7-ACCA – Kevin Flanigan, MD (Nationwide Children’s Hospital) SGT-001 – Carl Morris, PhD (Solid Biosciences) SRP-9001 – Teji Singh, MD (Sarepta Therapeutics) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 1:18:24 Panel Discussion: Facilitating Independence — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 31:10 The Landscape of Cardiac Care: Emerging Therapies on the Horizon — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 54:15 Emergency Care in Duchenne — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 8:36 Here Is What I Hear — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 39:20 The Future of Genetic Therapies — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 25:56 Gene Therapy Era: What We Know — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 32:14 Duchenne Siblings Panel: What We Want You To Know — PPMD 2022 Annual Meeting 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 34:37 Parent Panel: Things I’d Like My Doctor To Know — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings «1…7891011…25»Page 9 of 25
by: Parent Project Muscular Dystrophy
